Table of Contents

2019-2024 Global Pomalidomide Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Pomalidomide Consumption 2014-2024
  • 2.1.2 Pomalidomide Consumption CAGR by Region
• 2.2 Pomalidomide Segment by Type
  • 2.2.1 1mg Tables
  • 2.2.2 2mg Tables
  • 2.2.3 4mg Tables
• 2.3 Pomalidomide Consumption by Type
  • 2.3.1 Global Pomalidomide Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Pomalidomide Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Pomalidomide Sale Price by Type (2014-2019)
• 2.4 Pomalidomide Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drug Center
  • 2.4.3 Clinic
  • 2.4.4 Other
• 2.5 Pomalidomide Consumption by Application
  • 2.5.1 Global Pomalidomide Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Pomalidomide Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Pomalidomide Sale Price by Application (2014-2019)

3 Global Pomalidomide by Manufacturers

• 3.1 Global Pomalidomide Sales Market Share by Manufacturers
  • 3.1.1 Global Pomalidomide Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Pomalidomide Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Pomalidomide Revenue Market Share by Manufacturers
  • 3.2.1 Global Pomalidomide Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Pomalidomide Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Pomalidomide Sale Price by Manufacturers
• 3.4 Global Pomalidomide Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Pomalidomide Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Pomalidomide Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Pomalidomide by Regions

• 4.1 Pomalidomide by Regions
  • 4.1.1 Global Pomalidomide Consumption by Regions
  • 4.1.2 Global Pomalidomide Value by Regions
• 4.2 Americas Pomalidomide Consumption Growth
• 4.3 APAC Pomalidomide Consumption Growth
• 4.4 Europe Pomalidomide Consumption Growth
• 4.5 Middle East & Africa Pomalidomide Consumption Growth

5 Americas

• 5.1 Americas Pomalidomide Consumption by Countries
  • 5.1.1 Americas Pomalidomide Consumption by Countries (2014-2019)
  • 5.1.2 Americas Pomalidomide Value by Countries (2014-2019)
• 5.2 Americas Pomalidomide Consumption by Type
• 5.3 Americas Pomalidomide Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Pomalidomide Consumption by Countries
  • 6.1.1 APAC Pomalidomide Consumption by Countries (2014-2019)
  • 6.1.2 APAC Pomalidomide Value by Countries (2014-2019)
• 6.2 APAC Pomalidomide Consumption by Type
• 6.3 APAC Pomalidomide Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Pomalidomide by Countries
  • 7.1.1 Europe Pomalidomide Consumption by Countries (2014-2019)
  • 7.1.2 Europe Pomalidomide Value by Countries (2014-2019)
• 7.2 Europe Pomalidomide Consumption by Type
• 7.3 Europe Pomalidomide Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Pomalidomide by Countries
  • 8.1.1 Middle East & Africa Pomalidomide Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Pomalidomide Value by Countries (2014-2019)
• 8.2 Middle East & Africa Pomalidomide Consumption by Type
• 8.3 Middle East & Africa Pomalidomide Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Pomalidomide Distributors
• 10.3 Pomalidomide Customer

11 Global Pomalidomide Market Forecast

• 11.1 Global Pomalidomide Consumption Forecast (2019-2024)
• 11.2 Global Pomalidomide Forecast by Regions
  • 11.2.1 Global Pomalidomide Forecast by Regions (2019-2024)
  • 11.2.2 Global Pomalidomide Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Pomalidomide Forecast by Type
• 11.8 Global Pomalidomide Forecast by Application

12 Key Players Analysis

• 12.1 Celgene
  • 12.1.1 Company Details
  • 12.1.2 Pomalidomide Product Offered
  • 12.1.3 Celgene Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Celgene News
• 12.2 Natco Pharma
  • 12.2.1 Company Details
  • 12.2.2 Pomalidomide Product Offered
  • 12.2.3 Natco Pharma Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Natco Pharma News
• 12.3 Intas Pharmaceuticals
  • 12.3.1 Company Details
  • 12.3.2 Pomalidomide Product Offered
  • 12.3.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Intas Pharmaceuticals News
• 12.4 Indiabulls Pharmaceutical
  • 12.4.1 Company Details
  • 12.4.2 Pomalidomide Product Offered
  • 12.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Indiabulls Pharmaceutical News
• 12.5 Cipla
  • 12.5.1 Company Details
  • 12.5.2 Pomalidomide Product Offered
  • 12.5.3 Cipla Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Cipla News
• 12.6 Glenmark Pharmaceuticals
  • 12.6.1 Company Details
  • 12.6.2 Pomalidomide Product Offered
  • 12.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Glenmark Pharmaceuticals News
• 12.7 Dr Reddy's Laboratories
  • 12.7.1 Company Details
  • 12.7.2 Pomalidomide Product Offered
  • 12.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Dr Reddy's Laboratories News
• 12.8 Qilu Pharmaceutical
  • 12.8.1 Company Details
  • 12.8.2 Pomalidomide Product Offered
  • 12.8.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Qilu Pharmaceutical News
• 12.9 Chia Tai-Tianqing
  • 12.9.1 Company Details
  • 12.9.2 Pomalidomide Product Offered
  • 12.9.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Chia Tai-Tianqing News
• 12.10 Hanson Pharm
  • 12.10.1 Company Details
  • 12.10.2 Pomalidomide Product Offered
  • 12.10.3 Hanson Pharm Pomalidomide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Hanson Pharm News
• 12.11 Meidakang Huakang Pharmaceutical
• 12.12 Shandong Kongfu Pharmaceutical
• 12.13 SL PHARM

13 Research Findings and Conclusion

According to this study, over the next five years the Pomalidomide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pomalidomide business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pomalidomide market by product type, application, key manufacturers and key regions and countries.

This study considers the Pomalidomide value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
1mg Tables
2mg Tables
4mg Tables
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Center
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pomalidomide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pomalidomide market by identifying its various subsegments.
Focuses on the key global Pomalidomide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pomalidomide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pomalidomide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.